| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/03/2014 | WO2014104974A2 Self-assembling ultrashort peptides modified with bioactive agents by click chemistry |
| 07/03/2014 | WO2014104882A1 Method for improving postprandial fat digestion |
| 07/03/2014 | WO2014104871A1 Method for improving postprandial fat digestion |
| 07/03/2014 | WO2014104270A1 ANTIBODY RECOGNIZING FOLATE RECEPTORS α AND β |
| 07/03/2014 | WO2014103481A1 Cyclic peptide and pharmaceutical product containing same |
| 07/03/2014 | WO2014102782A1 Compositions and methods of killing bacteria |
| 07/03/2014 | WO2014102755A1 Bortezomib formulations |
| 07/03/2014 | WO2014102731A1 Novel pharmaceutical compositions of romidepsin |
| 07/03/2014 | WO2014102694A1 Novel mucinase for use in therapy or prophylaxis |
| 07/03/2014 | WO2014102623A1 Pharmaceutical composition |
| 07/03/2014 | WO2014102596A2 New cyclic cationic peptides with antimicrobial activity |
| 07/03/2014 | WO2014102570A1 Use of the compound pm181104, for the treatment of clostridium difficile associated infections |
| 07/03/2014 | WO2014102539A1 Delivery method using mesoporous silica nanoparticles |
| 07/03/2014 | WO2014102488A1 Cosmetic/dermatological composition |
| 07/03/2014 | WO2014102439A1 Method for obtaining useful data for predicting the response to the treatment of hepatitis c |
| 07/03/2014 | WO2014102426A1 Neuroprotective peptide and the use thereof in the treatment of cerebrovasuclar diseases and other pathological conditions of the cns |
| 07/03/2014 | WO2014102009A1 Anti-inflammatory peptides |
| 07/03/2014 | WO2014101748A1 Hemostatic or anticoagulant collagen material |
| 07/03/2014 | WO2014101294A1 Glycopeptide compound or pharmaceutical salt thereof and method for preparing same, and pharmaceutical compositions and applications thereof |
| 07/03/2014 | WO2014101287A1 Fusion protein of therapeutic polypeptide with improved pharmacokinetic profile and use thereof |
| 07/03/2014 | WO2014100913A1 Improving the half life of a therapeutic polypeptide by fusing with a trimeric scaffold protein via a spacer |
| 07/03/2014 | WO2014100901A1 Barley hordein and glutelin peptides having antioxidant activity |
| 07/03/2014 | WO2014100883A1 Hsp70 binding compound, use, antitumour pharmaceutical composition, gene construct for expressing an hsp70 binder, production process, process for evaluating tumour cells, method of sensitization of tumour cells to chemotherapeutic drugs |
| 07/03/2014 | WO2014100857A1 Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy |
| 07/03/2014 | WO2014100852A1 Inhibition of cancer growth and metastasis |
| 07/03/2014 | WO2014070971A3 Somatostatin-dopamine chimeric analogs |
| 07/03/2014 | WO2014066527A3 Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes |
| 07/03/2014 | US20140187601 Antisense oligonucleotide modulation of raf gene expression |
| 07/03/2014 | US20140187498 Predicting and treating diabetic complications |
| 07/03/2014 | US20140187497 Ocular Drug Delivery Devices |
| 07/03/2014 | US20140187496 Sgef controls macular, corpus callosum and hippocampal function and development, liver homeostasis, functions of the immune system, fever response atherosclerosis and tumorogenic cell growth |
| 07/03/2014 | US20140187495 Methods for treating glioblastoma |
| 07/03/2014 | US20140187494 Inhibition of inflammation using antagonists of muc1 |
| 07/03/2014 | US20140187490 Val (8) GLP-1 Composition and Method for Treating Functional Dyspepsia and/or Irritable Bowel Syndrome |
| 07/03/2014 | US20140187489 Mucosal delivery of drugs |
| 07/03/2014 | US20140187486 Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease |
| 07/03/2014 | US20140187485 Novel receptor nucleic acids and polypeptides |
| 07/03/2014 | US20140187484 Na/k-atpase-derived peptide src inhibitors and ouabain antagonists and uses thereof |
| 07/03/2014 | US20140187483 Glp-1 and methods for treating diabetes |
| 07/03/2014 | US20140187482 Insulin preparation |
| 07/03/2014 | US20140187480 Metabolic imprinting effects of specifically designed lipid component |
| 07/03/2014 | US20140187479 Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism |
| 07/03/2014 | US20140187478 Peptide toxin formulation |
| 07/03/2014 | US20140187476 Peptide derivative fusion inhibitors of hiv infection |
| 07/03/2014 | US20140187475 Lantibiotic Compositions and Methods For Preventing or Treating Mastitis |
| 07/03/2014 | US20140187470 Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| 07/03/2014 | US20140187441 Amplification of cyp24 and uses thereof |
| 07/03/2014 | US20140186887 RECEPTOR ACTIVATOR OF NF-kappaB |
| 07/03/2014 | US20140186459 Compositions and methods for forming and strengthening bone |
| 07/03/2014 | US20140186457 Honey composition with l-alanyl-l-glutamine |
| 07/03/2014 | US20140186446 Delivery of Biologic Therapeutics |
| 07/03/2014 | US20140186443 Cyclodextrin nanotechnology for ophthalmic drug delivery |
| 07/03/2014 | US20140186436 Oral delivery of enzymes by nanocapsules for targeted metabolism of alcohol or toxic metabolites |
| 07/03/2014 | US20140186433 Cosmetic Treatment System and Methods |
| 07/03/2014 | US20140186431 Combined mesenchymal stem cell transplantation and targeted delivery of vegf for treatment of myocardial infarction |
| 07/03/2014 | US20140186430 Cochleate compositions directed against expression of proteins |
| 07/03/2014 | US20140186423 Transdermal Patch Having Ultrasound Transducer for Administering Thrombolytic Reagents to Patients Having a Protein Misfolding Disease |
| 07/03/2014 | US20140186419 Use of sdf-1 to mitigate scar formation |
| 07/03/2014 | US20140186400 Methods and compositions for treating autoimmune diseases |
| 07/03/2014 | US20140186380 Immunotherapy with binding agents |
| 07/03/2014 | US20140186375 Combination of Immuno Gene Therapy and Chemotherapy for Treatment of Cancer and Hyperproliferative Diseases |
| 07/03/2014 | US20140186369 Method of modulating neovascularization |
| 07/03/2014 | US20140186368 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 07/03/2014 | US20140186364 Inhibition of the nt-3:trkc bound and its application to the treatment of cancer such as neuroblastoma |
| 07/03/2014 | US20140186357 Method for treatment of degenerative brain disorders comprising inhibitor of sum01 and bace1 interaction as an active ingredient |
| 07/03/2014 | US20140186337 Antitumors Combinations Containing Antibodies Recognizing Specifically CD38 And Bortezomib |
| 07/03/2014 | US20140186331 Body Weight Gain Suppresing Composition and Food Product Comprising the Same |
| 07/03/2014 | US20140186330 Treatment of gluten intolerance and related conditions |
| 07/03/2014 | US20140186325 Methods of Cancer Treatment and Prevention Through the Modulation of SIRT4 Activity |
| 07/03/2014 | US20140186311 Transient immortalization |
| 07/03/2014 | US20140186298 T-Cell Vaccination With Viral Vectors Via Mechanical Epidermal Disruption |
| 07/03/2014 | US20140186296 Methods for Treatment of HIV and Other Infections Using a T-Cell or Viral Activator and Anti-Retroviral Combination Therapy |
| 07/03/2014 | US20140186295 Methods and compositions for the treatment of cancer |
| 07/03/2014 | US20140186294 Phagocytic activity as a marker of synucleinopathic disease |
| 07/03/2014 | US20140186287 Ingestible formulations for transient, noninvasive reduction of gastric volume |
| 07/02/2014 | EP2749571A2 Methods of treating pain and inflammation in neuronal tissue using IL-31RA and OSMRb antagonists |
| 07/02/2014 | EP2749568A1 Cell dna synthesis prevention and cell proliferation inhibition polypeptide and use thereof |
| 07/02/2014 | EP2749290A2 Uses of recombinant super-compound interferons |
| 07/02/2014 | EP2749289A1 Anti-inflammatory peptides |
| 07/02/2014 | EP2749285A1 Osteogenesis promoter and use thereof |
| 07/02/2014 | EP2748334A1 A protein involved in detection of cancer metastasis and a treatment thereof |
| 07/02/2014 | EP2748190A2 Wnt compositions and therapeutic uses of such compositions |
| 07/02/2014 | EP2748183A1 Potent ligands of the ghrelin receptor |
| 07/02/2014 | EP2748181A1 Method for purification of cleaved pro-insulin |
| 07/02/2014 | EP2748177A1 Silk-based bioactive oligopeptide compositions and manufacturing process therefor |
| 07/02/2014 | EP2747784A1 Method for inhibiting cellular activation by insulin-like growth factor-1 |
| 07/02/2014 | EP2747776A2 Compounds for use in boosting coagulation |
| 07/02/2014 | EP2747775A2 Means and methods for treating angiogenesis-related diseases |
| 07/02/2014 | EP2747774A2 Methods and compositions for controlling assembly of viral proteins |
| 07/02/2014 | EP2747773A2 Methods and compositions comprising a c-terminal bax peptide |
| 07/02/2014 | EP2747764A1 Structural mimetics of proline-rich peptides and use thereof |
| 07/02/2014 | EP2747757A1 Methods for treating cardiovascular disorders |
| 07/02/2014 | CN103906761A 利钠多肽 Natriuretic peptide |
| 07/02/2014 | CN103906536A 恶病质治疗 Cachexia treatment |
| 07/02/2014 | CN103906530A 成纤维细胞生长因子21变体 Fibroblast growth factor 21 variant |
| 07/02/2014 | CN103906529A 充氦的制冷器 Helium refrigerators |
| 07/02/2014 | CN103906528A 用glp-1受体激动剂的缓释制剂治疗糖尿病的方法 With sustained-release formulations for treating diabetes method glp-1 receptor agonists |
| 07/02/2014 | CN103906527A Mrna递送的脂质纳米颗粒组合物和方法 Lipid nanoparticle composition and delivery method Mrna |
| 07/02/2014 | CN103906508A 治疗心血管疾病的方法 The method of treating cardiovascular disease |
| 07/02/2014 | CN103898101A 利用转基因动物乳腺生物平台大规模生产重组人丁酰胆碱酯酶的方法 Transgenic animal mammary gland platform scale production of recombinant human butyrylcholinesterase methods |